TNNI3 and proximal spinal muscular atrophy: Furthermore, hs-cTnI levels and their distribution in our cohort of neonates without SMA were similar to those in neonates with SMA, suggesting that the higher cTnI levels in our SMA cohort are primarily due to neonatal age rather than neuromuscular disease.